antwerpes ag

antwerpes develops and delivers creative marketing and communications concepts for the healthcare market. Based in Germany, we bring experience and expertise from a demanding healthcare environment to the European setting. While taking into account the strict regulations of the healthcare market, we offer a range of innovative solutions from a single source. antwerpes employs around 125 people and belongs to the DocCheck Group.

cambridge design

Cambridge Design Partnership

Cambridge Design Partnership is a technology and product design partner focused on helping clients grow their businesses.

Our experts work on innovation challenges addressing topics such as diagnostics, medical therapies, consumer health devices and packaging, and digital strategy, through a unique end-to-end service we call ‘Potential Realised’. We are also helping businesses enable commercial applications through technologies including AI, smart materials, and synthetic biology.

From front-end consumer Research for Innovation™, through new service, product strategy, and technology development, to manufacturing, our proven ISO 13485/9001-certified process ensures your solution is user-centred and commercially focussed – realising the value of your investment in innovation. Meet our friendly team at Curious 2018, or please contact hello@cambridge-design.co.uk


 Constantia Flexibles

Constantia Flexibles is the world’s fourth largest producer of flexible packaging. Based on the guiding principle of “People, Passion, Packaging,” around 7,500 employees manufacture tailor-made packaging solutions at 32 sites in 18 countries. Many international companies and local market leaders from the food and pharma industries choose the sustainable and innovative products of Constantia Flexibles. Focusing on anti-counterfeiting solutions, consumer safety and sustainable packaging Constantia Flexibles Pharma Division supports pharmaceutical manufacturers worldwide to meet their main challenges. Production sites operated in Austria, Germany, Italy, Spain, Vietnam, the UK and Belgium make Constantia Flexibles Pharma Division the world's second largest flexible packaging manufacturer for the pharmaceutical industry.



Since its establishment as a venture company from the University of Tsukuba in 2004, Cyberdyne has promoted the comprehensive development of various Cybernic Systems (Cybernic devices, Cybernic interfaces, etc.) that utilize Cybernic Technology from research and development to social implementation, aiming to tackle the various issues facing society. The company has developed business in the fields of medicine, welfare and daily living (including the work environment), and its main product, Robot Suit HAL®, is widely distributed not only in the medical and welfare fields but also in care support and labor support fields. In addition, new products such as Transportation Robot and Cleaning Robot equipped with artificial intelligence and environment recognition functions, HAL Lumbar Type for reduction of the load and stress on the lower back, smaller-sized HAL (Single-Joint Type), Vital Sensor for arteriosclerosis and arrhythmia measurements are continuously developed.


EIT Health


EIT Health is one of the largest healthcare initiatives worldwide. The initiative aims to sustainably advance the fundamentals of healthcare and thus promote suitable future conditions for healthy living, active ageing and improved wellbeing of people across Europe. EIT Health leverages the expertise of more than 140 member organizations from the pharma, diagnostics and med tech fields, payers, insurances, research institutions and universities. By investing in Europe’s best entrepreneurial talents and ideas, EIT Health fosters the development and commercialization of smart product and service solutions in the health sector, addressing the challenges posed by demographic change and ageing societies. 

ESA logo

European Space Agency (ESA)

The European Space Agency (ESA) is Europe’s gateway to space. Its mission is to shape the development of Europe’s space capability and ensure that investment in space continues to deliver benefits to the citizens of Europe and the world.

ESA is an international organisation with 22 Member States. By coordinating the financial and intellectual resources of its members, it can undertake programmes and activities far beyond the scope of any single European country. It is working in particular with the EU on implementing the Galileo and Copernicus programmes as well as with Eumetsat for the development of meteorological missions.
ESA develops the launchers, spacecraft and ground facilities needed to keep Europe at the forefront of global space activities.

Today, it develops and launches satellites for Earth observation, navigation, telecommunications and astronomy, sends probes to the far reaches of the Solar System and cooperates in the human exploration of space. ESA also has a strong applications programme developing services in Earth observation, navigation and telecommunications.



IQVIA brings human science and data science together. To power clinical expertise and real-world experience with the worlds’ best analytics and technologies to unleash a new way to solve healthcare’s most challenging problems. IQVIA mobilizes unparalleled data, analytics, technology, and expertise through solutions connecting stakeholders to improve health from molecule to market.



Microsoft enables digital transformation for the era of an intelligent cloud and an intelligent edge. Its mission is to empower every person and every organization on the planet to achieve more.




Leadvise is the German management consulting firm for Healthcare, Life Science and Chemicals clients, Banks, Telcos and Logistics corporates aiming to strengthen their execution power in strategy, innovation and digitalization. As part of the Reply Group we combine consulting services with extensive experience in digital technologies including Robotic Process Automation, the Internet of Things (IoT) and Big Data. We support your strategy implementation and operationalization, as well as the optimization of indirect business and support functions by leveraging technologies to intelligize your business. You benefit from short implementation cycles, our effective guidance and the measurable results even in complex and challenging environments.



NUVISAN is a fully integrated contract research organization, with a headcount of 315 employees. A  track record of nearly four decades as one of the first German CROs (est. 1979). Capabilities are distributed over three locations in Germany with a total space of nearly 18.000 m2. Additionally, NUVISAN has a balanced client portfolio comprising: pharmaceutical industry, biotech companies & academic institutions.


ReWalk Robotics

ReWalk Robotics develops, manufactures and markets wearable robotic devices for individuals with lower limb disabilities. The Company’s mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies.


Schrödinger GmbH

Schrödinger is the scientific leader in computational chemistry, providing software solutions and services for life science and materials science research, as well as enterprise-level software platforms. Schrödinger is committed to unparalleled product development and support. Founded in 1990, Schrödinger has operations within the US and in Europe, India, and Japan.

science exhibitor

Science AAAS

Since 1848, AAAS and its members have worked together to advance science and serve society. As part of these efforts, AAAS publishes Science, a multidisciplinary peer-reviewed journal, Science Advances, an open-access online journal, and several other online journals. AAAS also offers programs focused on science policy, international cooperation, science education, diversity, and career development for scientists.



Servier is an international pharmaceutical company governed by a non-profit foundation, with its headquarters in France (Suresnes). With a strong international presence in 148 countries and a turnover of 4.152 billion euros in 2017, Servier employs 21,600 people worldwide. Entirely independent, the Group reinvests 25% of its turnover (excluding generic drugs) in research and development and uses all its profits for development. Corporate growth is driven by Servier’s constant search for innovation in five areas of excellence: cardiovascular, immune-inflammatory and neuropsychiatric diseases, cancer and diabetes, as well as by its activities in high-quality generic drugs.